CVE:CMM - Canabo Medical Stock Price, News, & Analysis

eye icon Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume181,833 shs
Average Volume244,160 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Canabo Medical Inc, formerly Four River Ventures Ltd, is a Canada-based company, which is engaged in the provision of medical services and non-cannabinoid products for patients suffering from chronic pain and disabling illnesses through health clinics. The Company operates approximately 10 medical clinics across Canada. Its medical clinics are operated by qualified health care practitioners, independent medical marijuana evaluations for employers and insurers, and medical marijuana scientific research. The Company's subsidiary is Canabo Medical Corporation (CMC). Its CMClinics are located in Toronto, Barrie, Ottawa, Halifax, St. John's, Calgary, Edmonton, Stoney Creek, Hamilton and Burlington. Each clinic provides cannabinoid educators, who consult with patients to determine the proper treatment for their ailments using medical marijuana based on the medical documentation as prepared by the physician.

Industry, Sector and Symbol

Industry N/A



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive CMM News and Ratings via Email

Sign-up to receive the latest news and ratings for CMM and its competitors with MarketBeat's FREE daily newsletter.

Canabo Medical (CVE:CMM) Frequently Asked Questions

What is Canabo Medical's stock symbol?

Canabo Medical trades on the Canadian Venture Exchange (CVE) under the ticker symbol "CMM."

Has Canabo Medical been receiving favorable news coverage?

News stories about CMM stock have trended somewhat positive on Monday, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Canabo Medical earned a daily sentiment score of 1.4 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 7.0 out of 10, meaning that recent press coverage is likely to have an effect on the stock's share price in the immediate future. View News Stories for Canabo Medical.

What other stocks do shareholders of Canabo Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Canabo Medical investors own include Aurora Cannabis (ACB), Aphria (APHA), Canopy Growth (WEED), CytRx (CYTR), Heat Biologics (HTBX), Neovasc (NVCN), Reshape Lifesciences (RSLS), Shopify (SHOP), Biopharmx (BPMX) and 1933 Industries (TGIF).

Who are Canabo Medical's key executives?

Canabo Medical's management team includes the folowing people:
  • Alistair MacLennan, President, Chief Executive Officer, Director
  • Garry Stewart, Chief Financial Officer
  • Robert Coltura, Director (Age 50)
  • Jason E. Leikam, Independent Director (Age 41)

How do I buy shares of Canabo Medical?

Shares of CMM and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

How can I contact Canabo Medical?

Canabo Medical's mailing address is 1090 Georgia St W Suite 280, VANCOUVER, BC V6E 3V7, Canada. The company can be reached via phone at +1-604-8990106.

MarketBeat Community Rating for Canabo Medical (CVE CMM)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  20 (Vote Outperform)
Underperform Votes:  24 (Vote Underperform)
Total Votes:  44
MarketBeat's community ratings are surveys of what our community members think about Canabo Medical and other stocks. Vote "Outperform" if you believe CMM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CMM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/24/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel